Efficacy and safety signals from early-phase studies of KRAS inhibition in pancreatic cancer
K
Kathlen Oliveira Martins Tiede
M
Maria Fernanda Teixeira
M
Mariana Moura
O
Ohana Chiaini
F
Fernando Moura
M
Mohamad Bassam Sonbol
M
Mitesh Borad
T
Tanios Bekaii-Saab
(Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ)
P
Pedro Luiz Serrano Uson Junior
Article Details
Journal
Scientific Reports
Volume / Issue
Vol. 16, Issue 1
Published
March 11, 2026
ISSN
2045-2322
Publisher
Nature Portfolio
Authors (9)
K
Kathlen Oliveira Martins Tiede
M
Maria Fernanda Teixeira
M
Mariana Moura
O
Ohana Chiaini
F
Fernando Moura
M
Mohamad Bassam Sonbol
M
Mitesh Borad
T
Tanios Bekaii-Saab
Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
P
Pedro Luiz Serrano Uson Junior
Related Articles from this Journal
AI models of unstable flow exhibit hallucination
Ramdhan Wibawa, Birendra Jha
Aug 2026
10.1038/s41598-026-64023-8
The MCAA-YOLO + XPBI integrated model provides a hybrid intelligent measurement method for predicting the body weight of Hu sheep
Hang Zhang, Yuang Cheng et al.
Aug 2026
10.1038/s41598-026-64075-w
Application of iron nano-biofertilizers as a sustainable approach to enhance growth and micronutrient uptake in soybean
Ava Mohrazi, Reza Ghasemi-Fasaei
Aug 2026
10.1038/s41598-026-66011-4
Adolescents’ status-dependent public and private conformity to prosocial and antisocial decisions in a public goods game
Niloofar Saeedi, Khatereh Borhani et al.
Aug 2026
10.1038/s41598-026-64831-y
An explainable hierarchical capsule network framework for supporting expert sensory evaluation of herbal medicines with natural language generation
Hyein Lee, Dae-Hyun Jung
Aug 2026
10.1038/s41598-026-64156-w